Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Stromatt currently holds 65,786 shares of CELL THERAPEUTICS INC (CTIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Stromatt has been a net seller of CTIC stock. They have purchased $0 and sold $84.5K worth of shares.
Scott Stromatt's most recent insider trade was on Apr 4, 2008, when they sold 130,402 shares at $0.00 per share.
Scott Stromatt serves as Executive at CELL THERAPEUTICS INC (CTIC). They have executed 10 insider transactions totaling $84.5K over their tenure at the company.
Scott Stromatt holds the position of Executive at CELL THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Scott Stromatt has shown a selling trading pattern, with $0 in total purchases and $84.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Scott Stromatt was on Dec 22, 2006, when they sold $36.2K worth of CTIC shares. This transaction involved 20,000 shares at $1.81 per share.
Scott Stromatt currently owns 65,786 shares of CELL THERAPEUTICS INC (CTIC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Stromatt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Stromatt has 10 Form 4 filings on record as an insider at CELL THERAPEUTICS INC.
Set alerts for Scott Stromatt and 40,000+ other insiders.